Humanigen Inc (HGENQ)

[cowtown jay]

Interesting, isn't it, that the FDA cleared Gracell's 'GC012F' CAR-T IND application on Nov 27th, and then the next day, they announced that they were investigating the cancer risks linked to CAR-T therapy?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173299876

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173316333

Humanigen's latest patent, dated in June of this year, was to improve the, "Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab
Patent number: 11673962..."

https://patents.justia.com/assignee/humanigen-inc

Is Gracell realizing the reduced toxicities achieved by using lenz in their CAR-T, as described in our patent? Has this opened the eyes of the FDA to the avoidable adverse consequences of other CAR-T's?

Is there hope that using lenz as a covid vaccine adjuvant, which Humanigen has also patented, is yielding the same success for the prototype Novavax vaccine?